Production of Modified Vaccinia Ankara Virus by Intensified Cell Cultures: A Comparison of Platform Technologies for Viral Vector Production

Modified Vaccinia Ankara (MVA) virus is a promising vector for vaccination against various challenging pathogens or the treatment of some types of cancers, requiring a high amount of virions per dose for vaccination and gene therapy. Upstream process intensification combining perfusion technologies,...

Descripción completa

Detalles Bibliográficos
Autores principales: Gränicher, Gwendal, Tapia, Felipe, Behrendt, Ilona, Jordan, Ingo, Genzel, Yvonne, Reichl, Udo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7435511/
https://www.ncbi.nlm.nih.gov/pubmed/32762152
http://dx.doi.org/10.1002/biot.202000024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7435511/
https://www.ncbi.nlm.nih.gov/pubmed/32762152
http://dx.doi.org/10.1002/biot.202000024

Ejemplares similares